Koers Albert Labs International Corp. OTC Markets
Aandelen
ALBLF
CA0127841041
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- USD | -.--% | -.--% | -.--% |
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 2,73 mln. 2,51 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -1 mln. -921K | Nettowinst (verlies) 2022 | -7 mln. -6,45 mln. | EV/omzet 2021 * | - |
Nettoliquiditeiten 2021 | 76,7K 70,62K | Nettoliquiditeiten 2022 | 79,12K 72,85K | EV/omzet 2022 | - |
K/w-verhouding 2021 * |
-
| K/w-verhouding 2022 |
-0,32
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 84,71% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Robert Kang
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | 61 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Navchand Jagpal
COO | Chief Operating Officer | - | - |
Ravinder Kang
BRD | Director/Board Member | 58 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,79% | 50,93 mld. | |
-0,56% | 42,12 mld. | |
+49,62% | 42,05 mld. | |
-7,20% | 29,18 mld. | |
+12,59% | 26,02 mld. | |
-21,51% | 18,9 mld. | |
+6,92% | 13,21 mld. | |
+24,91% | 12,17 mld. | |
+29,60% | 12,16 mld. |
- Beurs
- Aandelen
- Koers ABRT
- Koers ALBLF